These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 76314)

  • 41. Lack of identity between TSTA and alien antigens of methylcholanthrene-induced murine sarcomas.
    Parmiani G
    Transplant Proc; 1980 Mar; 12(1):50-2. PubMed ID: 7368293
    [No Abstract]   [Full Text] [Related]  

  • 42. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
    Law LW
    Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenetic studies on meth-A-vaccinia tumour cells in vivo and in vitro.
    Garrido F; Schmidt W; Festenstein H
    J Immunogenet; 1977 Apr; 4(2):115-25. PubMed ID: 326975
    [No Abstract]   [Full Text] [Related]  

  • 44. Purification of tumor associated antigens from a methylcholanthrene induced murine sarcoma as monitored by humoral cytotoxicity.
    Ristow SS; Cleveland PH; Pier TR; McKhann CF
    Prep Biochem; 1975; 5(5-6):479-93. PubMed ID: 1215340
    [No Abstract]   [Full Text] [Related]  

  • 45. Measurement of H-2 antigen and immunogenicity of methylcholanthrene-induced murine sarcomas.
    Pearson T; Sikora K; Lennox E
    Br J Cancer; 1978 Apr; 37(4):530-5. PubMed ID: 77161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
    Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
    Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell-mediated immune reactions as probes of sensitization to tumour-associated antigens of methylcholanthrene-induced mouse sarcomas.
    Bubeník J; Indrová M; Malkovský M; Símová J
    Arch Geschwulstforsch; 1981; 51(4):349-53. PubMed ID: 6172086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
    Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Specific active immunotherapy of murine methylcholanthrene-induced sarcoma using a partially purified soluble tumor specific transplantation antigens].
    Tanaka T; Yamagishi H; Inaba S; Kobayashi M; Kurioka H; Naito K; Hashimoto I
    Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):282-94. PubMed ID: 6201713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-reacting tumor-specific transplantation antigens in methylcholanthrene-induced guinea pig sarcomas.
    Holmes EC; Morton DL; Schidlovsky G; Trahan E
    J Natl Cancer Inst; 1971 Apr; 46(4):693-700. PubMed ID: 4102340
    [No Abstract]   [Full Text] [Related]  

  • 51. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE; Adams JS; Santos GW
    J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
    [No Abstract]   [Full Text] [Related]  

  • 52. [Serological determination of specific surface antigens of cells from sarcomas induced by methylcholanthrene].
    Lezhneva OM
    Tsitologiia; 1970 May; 12(5):666-74. PubMed ID: 4915907
    [No Abstract]   [Full Text] [Related]  

  • 53. Purification and biochemical properties of tumor-associated transplantation antigens from methylcholanthrene-induced murine sarcomas.
    DuBois GC; Law LW; Appella E
    Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7669-73. PubMed ID: 6961442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fetal antigens shared as transplantation rejection antigens on chemically induced mouse and hamster sarcomas.
    Coggin JH; Adkinson L; Anderson NG
    Cancer Res; 1980 May; 40(5):1568-73. PubMed ID: 6768448
    [No Abstract]   [Full Text] [Related]  

  • 55. Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene.
    Bloom ET
    J Natl Cancer Inst; 1970 Sep; 45(3):443-53. PubMed ID: 5523193
    [No Abstract]   [Full Text] [Related]  

  • 56. Evidence of common antigenic properties in chemically induced sarcomas of mice.
    Reiner J; Southam CM
    Cancer Res; 1967 Jul; 27(7):1243-7. PubMed ID: 4952516
    [No Abstract]   [Full Text] [Related]  

  • 57. Assignment of the gene encoding for Meth A tumour rejection antigen (TATA) to chromosome 12 of the mouse.
    Law LW
    Br J Cancer; 1984 Jul; 50(1):109-11. PubMed ID: 6743507
    [No Abstract]   [Full Text] [Related]  

  • 58. Common tumor-associated antigens of chemically induced mouse sarcomas expressing murine leukemia virus antigens by primary in vitro sensitization.
    Saito T
    Fukuoka Igaku Zasshi; 1984 Mar; 75(3):137-48. PubMed ID: 6088376
    [No Abstract]   [Full Text] [Related]  

  • 59. Cross-immunity among syngeneic tumors of mice.
    Usubuchi I; Sobajima Y; Kudo H; Hongo T; Sugawara M
    Tohoku J Exp Med; 1972 Sep; 108(1):79-84. PubMed ID: 4648393
    [No Abstract]   [Full Text] [Related]  

  • 60. Actinomycin-D-resistant in vitro mouse cell line derived from a methylcholanthrene-induced sarcoma: decrease of malignancy and antigenic characteristics.
    Belehradek J; Biedler JL; Thonier M; Barski G
    Int J Cancer; 1974 Dec; 14(6):779-88. PubMed ID: 4142788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.